Evidence map›Paper›PMID 24845851›Full record

ReviewExperimental neurology2015

5-Hydroxymethylcytosine: A new player in brain disorders?

Ying Cheng, Alison Bernstein, Dahua Chen, Peng Jin

Abstract readReview
In one paragraph

Review in Experimental neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. DNA Methylation in Long-Term Memory.Physiology (Bethesda, Md.) · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ying ChengDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA; State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China.
Alison BernsteinDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Dahua ChenState Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China.
Peng JinDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: peng.jin@emory.edu.
Emory University · USChinese Academy of Sciences · CN

Funding

The Emory Alzheimer's Disease CenterP50AG025688 · NIA · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2005 to 2019
$25.7M
Molecular Basis of rCGG-Mediated NeurodegenerationR01NS051630 · NINDS · EMORY UNIVERSITY · PI NELSON, DAVID LOREN · 2006 to 2023
$9.8M
Tet-mediated Epigenetic Modulation in AutismR01MH102690 · NIMH · EMORY UNIVERSITY · PI JIN, PENG, WARREN, STEPHEN T. · 2014 to 2017
$2.6M
5-Hydroxymethylcytosine in NeurodevelopmentR01NS079625 · NINDS · EMORY UNIVERSITY · PI JIN, PENG · 2012 to 2016
$1.7M
Mapping 5-Hydroxymethylcytosine at single-Base Resolution in Human ES CellsR21HD073162 · NICHD · EMORY UNIVERSITY · PI JIN, PENG · 2012 to 2013
$425k
Epigenetic effects of adult and developmental exposure to parkinsonian toxicantsK99ES024570 · NIEHS · EMORY UNIVERSITY · PI BERNSTEIN, ALISON · 2014 to 2015
$175k
NIA NIH HHS P50 AG025688NICHD NIH HHS HD073162NICHD NIH HHS R21 HD073162NIEHS NIH HHS K99 ES024570NIMH NIH HHS R01 MH102690NINDS NIH HHS NS05163NINDS NIH HHS NS079625NINDS NIH HHS R01 NS051630NINDS NIH HHS R01 NS079625
6 · The paper itself

Abstract

5-Hydroxymethylcytosine (5 hmC), a novel modified cytosine, is oxidized from 5-methylcytosine (5 mC) by the ten-eleven translocation (Tet) protein family. The specific distribution of 5 hmC in mammalian brain and its roles in gene regulation suggest that 5 hmC is important in brain development. 5 hmC may also contribute to the mechanisms underlying neurological diseases. Here, we summarize the current knowledge of 5 hmC, with an emphasis on its roles in neurodevelopmental and neurodegenerative disorders.

Indexed as

5-MethylcytosineBrain DiseasesCytosineHumans5-hydroxymethylcytosine5-MethylcytosineCytosine5-Hydroxymethylcytosine (5hmC)5-Methylcytosine (5mC)Neurodegenerative diseaseNeurodevelopmental disorderTen-eleven translocation (Tet) protein

Identifiers

PMID24845851
PMCPMC4234697
OpenAlexW1965388596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.